The Patent Finder
IT

IFM Therapeutics, Inc.

First filing 2016
OverviewNotableFeesChangesPatent listSources & methods

0 patents currently held, every record listed here

3 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

This portfolio holds none of the 3 US patents in force on its record. from the record

Of the 3 now held by other companies, 3 name Novartis AG as their current owner. Each row says so.

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
none
Next term end

When these terms end

Each bar runs from grant to computed term end. 2022 to 2037.
US 11,447,460 Compounds and Compositions for Treating Conditions Associated with NLRP Activity Apr 18, 2037
US 11,339,136 Compounds and Compositions for Treating Conditions Associated with NLRP Activity Apr 18, 2037
US 11,597,706 Compounds and Compositions for Treating Conditions Associated with NLRP Activity Jun 3, 2037
20252028203120342037
Every computed term in this portfolio is shown above.Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
None of the currently held patents qualifies as notable.

Formerly held, still cited

Notable
The most cited patent in this portfolio, cited by 12 later US patents, top 10% of utility patents granted in 2022 in our data. Protection runs to 2037.
now held by Novartis AG
Ends Apr 2037 · High confidence
Also notable
Cited by 7 later US patents, top 10% of utility patents granted in 2023 in our data. Protection runs to 2037.
now held by Novartis AG
Ends Jun 2037 · High confidence
Also notable
Cited by 4 later US patents, top 25% of utility patents granted in 2022 in our data. Protection runs to 2037.
now held by Novartis AG
Ends Apr 2037 · High confidence

Fee deadlines

No maintenance fee falls due on this company's record before Nov 16, 2027.

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first.
Also on record: 3 patents in force now held by others · 1 application abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited